Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Carlsmed (CARL) Retained Earnings (2024 - 2026)

Carlsmed filings provide 2 years of Retained Earnings readings, the most recent being -$100.8 million for Q4 2025.

  • On a quarterly basis, Retained Earnings fell 41.64% to -$100.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$100.8 million, a 41.64% decrease, with the full-year FY2025 number at -$100.8 million, down 41.64% from a year prior.
  • Retained Earnings hit -$100.8 million in Q4 2025 for Carlsmed, down from -$92.2 million in the prior quarter.
  • In the past five years, Retained Earnings ranged from a high of -$71.2 million in Q4 2024 to a low of -$100.8 million in Q4 2025.